Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

89 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical Added Value of SARS-CoV-2 Antigen Detection in Blood Samples.
Oueslati S, Manai Bouokazi M, Ramdhani I, Escaut L, Pham T, Ouzani S, Anguel N, Bulifon S, Vauloup-Fellous C, Coilly A, Legros L, Guichardon M, Fortineau N, Dortet L, Roque-Afonso AM, Naas T. Oueslati S, et al. Among authors: escaut l. Diagnostics (Basel). 2022 Oct 7;12(10):2427. doi: 10.3390/diagnostics12102427. Diagnostics (Basel). 2022. PMID: 36292116 Free PMC article.
Efficacy of vancomycin lock therapy for totally implantable venous access port-related infection due to coagulase-negative staphylococci in 100 patients with cancer.
Lafaurie M, Montlahuc C, Kerneis S, de Lastours V, Abgrall S, Manceron V, Couzigou C, Chabrol A, de Raigniac A, Lescure X, Longuet P, Lesprit P, Vanjak D, Lepeule R; Groupe des référents en Infectiologie d’Ile de France (GRIF). Lafaurie M, et al. J Antimicrob Chemother. 2023 May 3;78(5):1253-1258. doi: 10.1093/jac/dkad083. J Antimicrob Chemother. 2023. PMID: 37014800
Effectiveness of third-generation cephalosporins or piperacillin compared with cefepime or carbapenems for severe infections caused by wild-type AmpC β-lactamase-producing Enterobacterales: A multi-centre retrospective propensity-weighted study.
Maillard A, Delory T, Bernier J, Villa A, Chaibi K, Escaut L, Contejean A, Bercot B, Robert J, El Alaoui F, Tankovic J, Poupet H, Cuzon G, Lafaurie M, Surgers L, Joseph A, Paccoud O, Molina JM, Bleibtreu A; Treatment of AmpC-producing Enterobacterales Study Group. Maillard A, et al. Among authors: escaut l. Int J Antimicrob Agents. 2023 Jul;62(1):106809. doi: 10.1016/j.ijantimicag.2023.106809. Epub 2023 Apr 6. Int J Antimicrob Agents. 2023. PMID: 37028731
Antimicrobial for 7 or 14 Days for Febrile Urinary Tract Infection in Men: A Multicenter Noninferiority Double-Blind, Placebo-Controlled, Randomized Clinical Trial.
Lafaurie M, Chevret S, Fontaine JP, Mongiat-Artus P, de Lastours V, Escaut L, Jaureguiberry S, Bernard L, Bruyere F, Gatey C, Abgrall S, Ferreyra M, Aumaitre H, Aparicio C, Garrait V, Meyssonnier V, Bourgarit-Durand A, Chabrol A, Piet E, Talarmin JP, Morrier M, Canoui E, Charlier C, Etienne M, Pacanowski J, Grall N, Desseaux K, Empana-Barat F, Madeleine I, Bercot B, Molina JM, Lefort A; PROSTASHORT Study Group. Lafaurie M, et al. Among authors: escaut l. Clin Infect Dis. 2023 Jun 16;76(12):2154-2162. doi: 10.1093/cid/ciad070. Clin Infect Dis. 2023. PMID: 36785526 Clinical Trial.
Effectiveness of temocillin in treatment of non-urinary tract infections caused by ESBL-producing Enterobacterales and risk factors for failure.
Mamona Kilu C, Menvielle C, Cataldi A, Hamon A, Duran C, Mwanba C, Tesmoingt C, Bouabdallah-Perrin L, Touche P, Chanh Hew Wai A, Ourghanlian C, Antignac M, Bildan MA, Bleibtreu A, Michelon H, Diamantis S, Pilmis B, Citerne A, Farfour E, Dinh A; Paris Temocillin study group. Mamona Kilu C, et al. JAC Antimicrob Resist. 2024 Oct 17;6(5):dlae164. doi: 10.1093/jacamr/dlae164. eCollection 2024 Oct. JAC Antimicrob Resist. 2024. PMID: 39421154 Free PMC article.
Extrapulmonary Mycobacterium abscessus Infections, France, 2012-20201.
Heid-Picard B, Mougari F, Pouvaret A, Lanternier F, Awad Z, Bille E, Lortholary O, Cambau E; Mabsc Study Group. Heid-Picard B, et al. Emerg Infect Dis. 2024 Nov;30(11):2294-302. doi: 10.3201/eid3011.240459. Emerg Infect Dis. 2024. PMID: 39447147 Free PMC article.
89 results